tiprankstipranks
Vascular Biogenics (VBLT)
NASDAQ:VBLT
US Market

Vascular Biogenics (VBLT) Stock Forecast & Price Target

705 Followers
See the Price Targets and Ratings of:

VBLT Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Vascular
Biogenics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

VBLT Stock 12 Month Forecast

There Are No Analyst Ratings for VBLT In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

VBLT Financial Forecast

VBLT Earnings Forecast

Next quarter’s earnings estimate for VBLT is -$0.41 with a range of -$0.41 to -$0.41. The previous quarter’s EPS was -$0.40. VBLT beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.70% of the time in the same period. In the last calendar year VBLT has Underperformed its overall industry.
Next quarter’s earnings estimate for VBLT is -$0.41 with a range of -$0.41 to -$0.41. The previous quarter’s EPS was -$0.40. VBLT beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.70% of the time in the same period. In the last calendar year VBLT has Underperformed its overall industry.

VBLT Sales Forecast

Next quarter’s sales forecast for VBLT is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. VBLT beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 44.82% of the time in the same period. In the last calendar year VBLT has Outperformed its overall industry.
Next quarter’s sales forecast for VBLT is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. VBLT beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 44.82% of the time in the same period. In the last calendar year VBLT has Outperformed its overall industry.

Best Analysts Covering Vascular Biogenics

Which Analyst Should I Follow If I Want to Buy VBLT and Sell After:
1 Month
No data currently available
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
3 Months
No data currently available
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
1 Year
Unknown AnalystJMP Securities
Not Ranked
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
initiated a buy rating 6 months ago
Copying Unknown Analyst's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
2 Years
No data currently available
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

VBLT Analyst Recommendation Trends

Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

VBLT Stock Forecast FAQ

What is VBLT’s average 12-month price target, according to analysts?
Currently, no data Available
What is VBLT’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for VBLT, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is VBLT a Buy, Sell or Hold?
      Currently, no data Available
      What is Vascular Biogenics’s price target?
      Currently, no data Available
      What do analysts say about Vascular Biogenics?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of VBLT?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis